Sequencing Explains 'Outlier' Patient Response to Everolimus, Shows Promise … – GenomeWeb
Sequencing Explains 'Outlier' Patient Response to Everolimus, Shows Promise …GenomeWebSequencing the genome of a cancer bladder patient who responded exceptionally well to a cancer drug that failed in most other patients in a clinical trial, …
